- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Oncology MDTV - Page 23
Explanation to why immunotherapies don't work on hardest-to-treat...
The process of surviving chemotherapy triggers a program of immune checkpoints that shield breast cancer cells from...
Exercise, even in late stages of the disease suppresses growth of...
Previous work from ECU's Exercise Medicine Research Institute has shown men with advanced prostate cancer can change...
Late-breaking research results for acute lymphoblastic leukemia (ALL)
Acute lymphocytic leukemia (ALL) is a kind of blood and bone marrow malignancy. Blood cells are generated in the spongy...
Modakafusp alfa shows promise in treating multiple myeloma, study...
According to the American Cancer Society, about 12,640 deaths from multiple myeloma are expected to occur in the U.S....
73 percent of patients in two clinical trials exhibit success in...
Nearly all patients with myeloma who receive standard therapies continually relapse. Patients who relapse or become ...
Adjuvant chemotherapy improves overall survival for pancreatic cancer...
Cancer that develops in pancreatic cells is known as pancreatic cancer. The pancreas is an organ in your abdomen that...
Capivasertib addition to fulvestrant improves progression-free...
Patients with HR-positive, HER2-negative breast cancer are commonly treated in the first line with an endocrine...
TAILORx trial's 12 years of recurrence and survival outcomes in more...
Estrogen receptor-positive (ER+) and HER2-negative (HER2-) breast cancer with no spread to the lymph nodes accounts ...
Researchers discover mechanism that allows cancer cells to spread
An international team of researchers has uncovered a new mechanism that enables cancer cells to move throughout the...
Expression of estrogen-related gene can impact post-menopausal breast...
In a study using a first-of-its kind mouse model of aging that mimics breast cancer development in estrogen...
Cancer-fighting nanoparticles co-delivering a chemotherapy drug &...
Chemotherapy is a pillar of cancer treatment, but residual cancer cells can persist and cause tumor relapse. This ...
Healthy plant-based diets linked with lower colorectal cancer risk in...
Researchers from Kyung Hee University, South Korea found that, among a population of close to 80000 American men, those...